Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-23-001689
Filing Date
2023-02-14
Accepted
2023-02-14 09:40:22
Documents
1

Document Format Files

Seq Description Document Type Size
1 MONTE ROSA THERAPEUTICS, INC. p23-0270sc13ga.htm SC 13G/A 58763
  Complete submission text file 0000902664-23-001689.txt   60399
Mailing Address 110 GREENE STREET SUITE 800 NEW YORK NY 10012
Business Address 110 GREENE STREET SUITE 800 NEW YORK NY 10012 212-937-4975
Avoro Capital Advisors LLC (Filed by) CIK: 0001633313 (see all company filings)

EIN.: 271007403 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 645 SUMMER STREET SUITE 102 BOSTON MA 02210
Business Address 645 SUMMER STREET SUITE 102 BOSTON MA 02210 617-949-2643
Monte Rosa Therapeutics, Inc. (Subject) CIK: 0001826457 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92649 | Film No.: 23623545
SIC: 2836 Biological Products, (No Diagnostic Substances)